✦ LIBER ✦

The view of the pharmaceutical industry

✍ Scribed by Gilles Roche; Jean-Pierre Heienport

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 125 KB
Volume: 88
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(94)90477-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Clinical Drug Resea

ChemInform Abstract: Clinical Drug Research in Germany — Problems and Chances — From the Pharmaceutical Industry′s Point of View

✍ Thomas R. Weihrauch; Eberhard Baumbauer 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

Transporters – The View from Industry

✍ Christopher Kohl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Industry perspective. The view of the cl

Industry perspective. The view of the cleanup industry on superfund reauthorization

✍ Patrick F. O'Hara; Carolyn M. Kiely 📂 Article 📅 1998 🏛 John Wiley and Sons ⚖ 572 KB

Epidemiology in the pharmaceutical indus

Epidemiology in the pharmaceutical industry

✍ Lewis H Roht; Lauren Shinaberry; Lucy Maybury; Irene Liao; Elinor Riley; Elizabe 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

A survey assessing the practice of epidemiology in the pharmaceutical industry was sent to all member companies and research affiliates of the Pharmaceutical Research and Manufacturers of America (PhRMA) and to six non-member companies. Eighty-three companies were surveyed. Screening questions estab

Fine Chemicals (The Industry and the Bus

Fine Chemicals (The Industry and the Business) || Ethical Pharmaceutical Industry

✍ Pollak, Peter 📂 Article 📅 2011 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 682 KB

Prologue: Chirality in the Pharmaceutica

Prologue: Chirality in the Pharmaceutical Industry

✍ Prof. John Caldwell; Prof. Nina Berova; Dr. Oliver McConnell 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

In a period of just 15 years, there has been a remarkable shift in the composition of life-improving and life-saving pharmaceutical drugs that have been brought to the marketplace. The shift has been a precipitous drop from nearly a third of the active ingredients comprised of racemic or diastereome